Company: HUM
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-048976
Chunk: 17

Company: HUMANA INC
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 17
---
 Information Officer, succeeding Samir M. Deshpande, effective February 2025. In this role, Mr. Mehta will oversee our digital and technology organization and data systems, as well as set the technology transformation vision for Humana to better connect consumers to their caregivers and enable better clinical decision making, while also driving greater efficiencies through technology modernization. In making this decision, the Board recognized Mr. Mehta’s more than two decades of experience leading technology teams in large-scale, regulated industries focused on delivering customer-centric solutions. |     |                           |     |                   |     |             |

The Board will continue to evaluate the succession planning processes on a regular basis, and provide transparency on our approach to attracting, retaining and cultivating future generations of leadership at the Company. For more information on the role our compensation program plays in this process – including properly incentivizing our management team to progress on Humana’s strategic priorities and core business drivers – please refer to the “Compensation Discussion and Analysis” of this proxy statement. Stockholder Engagement The Board, together with its committees and the Company’s management team, routinely interacts with our stockholders, and reviews and responds to the feedback received from them – through formal stockholder engagements, stockholder voting results and routine communication during the year – creating a feedback loop of transparency into our compensation and governance practices. The continuous dialogue supplements the Board’s customary review of our governance and compensation programs, policies and/or practices as it considers areas for enhancement or improvement. In addition to the above interactions, the Company routinely meets with stockholders, prospective investors, and analysts throughout the year during industry conferences and other events. The Company’s meeting schedule, presentations to investors and webcast replays are available via the Investor Relations section on our website. From www.humana.com, click on “More Humana” then click on “For Investors” and then click on the tab for “Calendar of Events” or “Historical Webcasts and Presentations.” 2024 Engagement Campaign We have a long-standing practice of proactive engagement with our stockholders through an annual fall campaign to facilitate open lines of dialogue and understand stockholder perspectives. Throughout this process, the Company offers participation by members of the Board and management team. During our 2024 outreach, Kurt J. Hilzinger, the Chairman of our Board, and Karen W. Katz, the Chair of our Nominating, Governance, & Sustainability Committee, participated in discussions with certain stockholders. The Board values the perspectives shared during 2024 across a range of topics